Archive | Innovation Challenge RSS feed for this section

Get Your Name Out – Win a Pitch Spot in the RESI Asia Innovation Challenge!

19 Sep

By Claire Jeong, Director of Research, Asia BD, LSN

claireAfter another successful RESI Boston last week, we are excited to talk about our inaugural RESI Asia events, RESI Shanghai (November 12th) and RESI Taipei (November 14th)!

Life Science Nation would like to invite all early-stage life science companies across the globe to apply for the RESI Asia Innovation Challenge through our online portal. Selected finalists will present a poster showcasing their company and technology at our exhibition hall on the day of RESI. All participants will be presented with “RESI Cash” to “invest” in their favorite technologies. This time, we have another special opportunity for the Innovation Challenge finalists!

For the very first time, our RESI Asia conferences will feature a full day track dedicated to pitch sessions, during which companies will present a short pitch in front of a panel of active investor judges. At both RESI Shanghai and RESI Taipei, companies who are selected for the Innovation Challenge will also be granted an opportunity to be part of a pitch session. In combination, the Innovation Challenge and pitch sessions will provide unparalleled exposure to participating early-stage companies who are seeking to meet and grow relationships with new and existing investors for their fundraising efforts.

To shed some light on what the Innovation Challenge is like from the participating company’s point of view, the 1st place winner of the Innovation Challenge at RESI Boston, Zepto Life Technology, shared some comments about their experience at RESI. Jason Payne, Director of Business Development & Investor Relations at Zepto, said, “The RESI Innovation Challenge provided a truly excellent opportunity for my team to showcase Zepto’s pioneering GMR-based “lab-on-a-chip” biotechnology, ahead of our firm’s upcoming $30 million Series A round in 1Q 2020. RESI’s team of well-practiced professionals equipped Zepto with expert guidance throughout each step of the process — from our team’s initial creation of Zepto’s poster through the entire RESI conference’s celebration of Zepto’s eventual 1st Place finish. Moreover, the RESI conference’s excellent web-based scheduling system allowed Zepto to launch our firm’s Series A outreach in style, introducing my team to numerous potential investors with a simple click of my mouse. Thanks to RESI, Zepto’s fundraising process is off to a wonderful start!”

Carmit Levy, CEO of ResMetrix Medical, 3rd place winner in the Innovation Challenge at RESI Boston, added, “The RESI Innovation Challenge provided a great opportunity for Resmetrix to present our unique wearable system for accurately monitoring lung disease patients at home and alert for early signs of deterioration. It opened the possibility to meet other participants that were interested to hear more about Resmetrix technology on top of the meetings that we set before with investors, through the wonderful meetup system on RESI website. Winning 3rd place in RESI challenge also exposed Resmetrix to additional potential investors. Thank you RESI for this great opportunity!”

I’ve also interviewed Soundable Health’s CEO Catherine Song, who won 1st place at the RESI Philadelphia Innovation Challenge in June (you can read it here).

Applying for the Innovation Challenge is free – get started on your application now!

RESI ASIA Innovation Challenge Deadline is Oct. 11th, 2019

From 38 Finalists, RESI Boston’s Audience Selects Innovation Challenge Champions

12 Sep

By Lucy Parkinson, VP of Investor Research, LSN

Yesterday’s RESI event brought together over 350 investors and over 350 startups in Boston’s Back Bay.  There were so many meetings that RESI Partnering filled to capacity.  LSN is delighted to have facilitated so many new connections, and we hope that these relationships continue to grow in the follow-up.

The RESI Innovation Challenge showcased 38 emerging startups in the biotech, medtech, diagnostics and digital health fields.  All the competitors brought novel, exciting discoveries to the technology showcase, selected by LSN’s Expert System and scientific review team.  RESI’s attendees chose the winners by using their RESI Cash tokens to cast votes for their favorite participants.  We would like to introduce you all to the 3 top placed companies, as selected by the RESI ecosystem.  Thank you, all, for taking part by casting your votes.

First Place: Zepto Life Technologies

Zepto, an in-vitro diagnostics company, features uniquely-accurate and multiplex-ready “lab-on-a-chip” technology – co-developed with the Mayo Clinic – to improve patient outcomes through superior assay performance at patients’ exact points of need (a $12B market). Zepto’s fully-automated lab-on-a-chip Immunoassay Platform can conveniently deliver “central lab-quality” performance almost anywhere. Initially, Zepto is working to equip ERs and ambulances with highly-sensitive Troponin assays, accelerating myocardial injury detection. Meanwhile, Zepto’s portable Liquid Biopsy Platform can detect 1% cancer gene mutation (eg. PIK3CA, EGFR, KRAS) and achieve unparalleled specificity of 99.9%+ in less than 2 hours. This can revolutionize the $6B tissue-based biopsy market. Zepto seeks $30M, primarily to launch the Immunoassay Platform with D-Dimer assays and complete PIK3CA-focused product development on the Liquid Biopsy Platform.

YongYong Zhang, CEO & Co-Founder, Zepto Life Technologies


Second Place: BOYDSense

BOYDSense, Inc. is a medical technology company providing non-invasive and affordable tools for measuring critical biomarkers via exhaled breath. Breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using them to diagnose and monitor chronic diseases, such as diabetes. BOYDSense’s first commercial product, the g-Sense Breath Meter, is a hand-held breath meter that can accurately predict blood glucose values from breath VOC’s. The g-Sense meter does not need consumables, is wirelessly enabled, has a companion mobile application and a public API. The device design is lifestyle-friendly, pocket-sized, with a seamless user experience, allowing consumers to frequently measure blood glucose without the typical barriers of cost, pain, or social stigma.

Bruno Thuillier, CEO, BOYDSense


Third Place: Resmetrix Medical

Respiratory diseases are leading causes of death and disability in the world. More than 250 million people suffer from Chronic Obstructive Pulmonary disease (COPD) and 300 million from Asthma worldwide. Currently, respiratory deterioration is often detected too late, leading to sever exacerbation and complications, hospitalization and huge costs. Resmetrix is developing a wearable system (based on unique proprietary sensor built into a chest strap wirelessly connected to a smartphone app), that monitors at-risk respiratory patients in real-time, 24/7, anywhere, in any setting. Resmetrix system is the only system that detects small changes in a patient’s breathing pattern and provides immediate, early warning signs of deterioration in COPD patients at home, enable early window of intervention, early treatment and avoiding hospitalization.

Carmit Levy, Ph.D., CEO, Resmetrix Medical

RESI ASIA Innovation Challenge Deadline is Oct. 11th, 2019

Israeli Startups Make a Big Impact at RESI

12 Sep

By Karen Deyo, Senior Investor Research Analyst, LSN

Israel is frequently referred to as ‘The Startup Nation,’ with a lot of innovative technologies being developed in a multitude of sectors, including in healthcare. Over the past year, LSN has worked with the Israel Ministry of the Economy, the Israel Export Institute, the Israel Innovation Authority, the New England-Israel Business Council and several incubators and accelerators within Israel to bring these companies into the global RESI ecosystem.

In the 4 RESIs that have taken place so far in 2019, about 20 Israeli companies have been selected as finalists in the Innovation Challenge, with a few companies among the winners of these conferences. Yesterday, at RESI Boston, a group of these Israeli companies came to meet with the global investor attendees, including Novotalk, 1st place winner at RESI SF, PhotoPill Medical, 2nd place winner of RESI Europe, and Resmetrix, 3rd place winner yesterday. We look forward to seeing many more exciting companies from Israel at future RESIs, and hope that they will be as successful as the companies that have attended so far!

Izik Itzhakov of AEYE Health | Zohar Beeri of Novotalk | Ram Ben-Yehuda of PhotoPill Medical | Sharon Ben-Yehuda of PhotoPill Medical | Carmit Levy of Resmetrix Medical | Karen Deyo, Senior Investor Research Analyst, Life Science Nation

Meet the Innovation Challenge Finalists at RESI Boston 2019

22 Aug

By Gregory Mannix, Vice President International Business Development, LSN

We are happy to anounce the finalists who will compete in the RESI Boston Innovation Challenge on September 11th at the Westin Copley Place hotel. As is always the case, we received many great applications from cutting edge technologies across the four main life science silos: Drugs, Devices, Diagnostics and Digital Health. Also, we will again feature a number of grant recipients from the NIH/SBIR program, a program we have coordinated with the NIH for 4 years now. In total, 40 companies will present a poster on the day of the conference, taking advantage of this unique opportunity to “socialize” their projects to conference attendees and seek their RESI cash to win one of the top places in the competition for valuable prizes. As always, competing in the RESI Innovation Challenge has no cost for companies, but offers much to gain. Congratulations and good luck to the finalists!


Medical Devices


Digital Health

Don’t forget to apply to the RESI Innovation and Pitch Challenges before Aug 7th!

1 Aug

By Karen Deyo, Senior Investor Research Analyst, LSN

Whether you are a startup applying to be a finalist in the RESI Innovation Challenge, or a constituent of a registered First Coast tech hub vying for a spot in the Innovators’ Pitch Challenge, participation in these Challenges can be good for a company beyond RESI. In addition to the increased exposure at RESI, companies have also found that being able to highlight participation can be a boost when speaking with potential investors. The application deadline for the Innovation and Pitch Challenges is next Wednesday, Aug 7th and we encourage you to submit your application for consideration!

Click below for articles with interviews from previous Innovation Challenge winners and Pitch Challenge participants

Tech Hubs in the Spotlight at RESI Boston 2019

25 Jul

By Bryanna Allison, Business Development Manager, LSN

We are in the age of the incubator. Sprouting up in biotech hubs such as Boston, around universities and research hospitals at a rapid rate — these facilities are intended to help entrepreneurs take those difficult first steps. With new technologies developing at an accelerated rate, it just makes sense. Starting your own company is risky, bootstrapping is even riskier. An incubator serves to soften this risk and give budding entrepreneurs some of the support and advice they need to make their company a success.

With investors and strategic partners looking earlier, either for partnerships or to keep an eye on potential future investments, it only made sense to incorporate these tech hubs into our ecosystem, creating a special segment for them at our RESI Conference in Boston last fall.

In September of 2018 LSN launched our first ever “First Coast Innovators’ Gathering” at RESI. We invited incubators, accelerators, tech transfer or regional organizations based on the East Coast from DC to Boston to not only exhibit their programs but to bring their constituents to meet with the early stage investors at RESI. These tech hubs could benefit from the exposure they receive, form relationships with investors who may be interested in their portfolio companies, while the constituents could meet potential investors or even form relationships for the future and get investor feedback on what they need to become more relevant.

To great success, LSN has incorporated a tech hub component into every conference since. RESI will be back in Boston on Sept. 11th, and joining us will be the second First Coast Innovators’ Gathering will be the following tech hubs:


Regional Spotlight: “First Coast”

18 Jul

By Gregory Mannix, Vice President International Business Development, LSN

The 2019 RESI Boston Fall conference will again feature the First Coast Innovators’ Gathering, showcasing the hottest new technologies being developed in the tech hubs from the Northeast Corridor region—from Boston to DC—which we have denominated the “First Coast”.

This unique region is truly moving the needle in the life sciences, and the numbers show it. The region is extraordinary in many ways: total investment dollars in life sciences companies, grant awards by the National Institutes of Health, number of top incubator and accelerator programs, world-class medical facilities, etc.

The region was number one in the world in total biopharma investments and series A investments in the space, and near the top in medical devices and diagnostics.*

19 of top 50 NIH grant recipient institutions in 2018 were in the First Coast Region, receiving over $2.3 billion in awards**
*SVB 2019 Annual Report
**Genetic Engineering and Biotechnology News, June 4th, 2019

First Coast Innovators Gathering

Investors are looking to identify the hottest new technologies at earlier and earlier stages of development, which is why we got such positive feedback about the first edition of the Innovators’ Gathering at RESI Boston 2018. Tech hubs from DC to Boston gathered at RESI and exhibited information about their programs and cutting-edge companies.  Investors and strategic partners were able to get to know many of the tech hubs from the region and interact with their staff and companies who were attending.

Likewise, tech hubs necessarily aim to nurture and grow their networks of key players in the life sciences ecosystem in order to offer the most value to their constituents. The Innovators’ Gathering provides a perfect platform to accomplish this.

“The visibility is extremely beneficial for us. It helps us maintain a pipeline of resident companies and it provides ample opportunity  to meet potential investors and industry partners.”

Mary Ann Picard, COO at M2D2 Incubator

Another benefit of the Gathering is that it gives the earliest stage companies—companies that are working out of these tech hubs—access to the RESI conference at a discounted price.  All of these tech hub constituent companies can apply to compete in the Innovators’ Pitch Challenge, an opportunity to pitch to a panel of 5 investors and be able to follow up with them after the conference.

This year we will host the second edition of the First Coast Innovators’ Gathering, and we look forward to welcoming back the amazing tech hubs and their constituent companies that made the first edition such a success. RESI Boston and the Innovators’ Gathering will be held on September 11th at the Westin Copley Hotel.

%d bloggers like this: